Most of the mature players in the TBI field - biotech, pharma, academic, believe that combination therapy will likely be required for a condition as variable as TBI. As to who's eyeing who, I'd say they're all watching each other and waiting for results and there are lots of background discussions going on. It was interesting to see some big pharma names (J&J, Pfizer, Sanofi-Aventis) at the TBI conference.
Most of the mature players in the TBI field - biotech, pharma,...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |